ArticleBMC medical informatics and decision making2025
Early classification of functional connectomes in Parkinson's disease: a comparison of machine learning classifiers using multi-scale topological features.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundParkinson’s disease (PD) affects brain networks across multiple anatomical scales, but it is unclear how correctly machine learning (ML) would classify the (altered) topology of functional connectomes in single PD cases at an early clinical stage. Leveraging network graph theory (NGT) for multi-scale topological feature extraction, here we determined (i) which features (across scales, lobes and types) are relatively more important, and (ii) which current state-of-the-art ML classifiers provide better performances, when discriminating newly diagnosed, drug-naive PD patients vs. healthy control (HC) subjects in a single-center MRI study.
methodsResting-state functional MRI was consecutively performed in 112 drug-naïve PD patients and 17 HC subjects. Following standard (automated) preprocessing, the Brainnetome atlas (210/36 cortical/subcortical areas) was applied to reconstruct individual functional connectomes. NGT features were extracted at global, lobar/cortical and lobar/subcortical scales. Feature importance was assessed as the information gain (IG) criterion. The synthetic minority oversampling technique (SMOTE) was used to augment HC datasets. Nine different ML classifiers were trained on discriminating PD vs. HC (balanced) classes and validated via repeated stratified cross-validation.
resultsAmong global NGT features, characteristic path length (IG = 20.3%) was more important than global (IG ~ 14%) and average local (IG ~ 14%) efficiency. Basal ganglia (IG = 18.5%), parietal cortex (IG = 17.7%) and thalamus (IG = 15.6%) cumulatively contributed the most informative NGT features. The “extra-tree classifier” achieved the best performances (F1-score = 95.8 ± 3.8%; AUCROC = 99.3 ± 1.8%).
conclusionsBoth global and local NGT features are important for the topological classification of functional connectomes in drug-naïve PD patients. Combining multi-scale functional connectomics with ML may contribute to the design of health information technologies (for decision-making) and for the definition of early, accurate and interpretable, non-invasive neuroimaging PD biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.